These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 14764711)
1. Macrophages, CD4+ or CD8+ cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma. Rothfuchs AG; Kreuger MR; Wigzell H; Rottenberg ME J Immunol; 2004 Feb; 172(4):2407-15. PubMed ID: 14764711 [TBL] [Abstract][Full Text] [Related]
2. STAT1 regulates IFN-alpha beta- and IFN-gamma-dependent control of infection with Chlamydia pneumoniae by nonhemopoietic cells. Rothfuchs AG; Trumstedt C; Mattei F; Schiavoni G; Hidmark A; Wigzell H; Rottenberg ME J Immunol; 2006 Jun; 176(11):6982-90. PubMed ID: 16709859 [TBL] [Abstract][Full Text] [Related]
3. Protective DNA immunization against Chlamydia pneumoniae. Svanholm C; Bandholtz L; Castaños-Velez E; Wigzell H; Rottenberg ME Scand J Immunol; 2000 Apr; 51(4):345-53. PubMed ID: 10736106 [TBL] [Abstract][Full Text] [Related]
4. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma. Day YJ; Huang L; Ye H; Li L; Linden J; Okusa MD J Immunol; 2006 Mar; 176(5):3108-14. PubMed ID: 16493070 [TBL] [Abstract][Full Text] [Related]
5. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. Rottenberg ME; Gigliotti Rothfuchs AC; Gigliotti D; Svanholm C; Bandholtz L; Wigzell H J Immunol; 1999 Mar; 162(5):2829-36. PubMed ID: 10072530 [TBL] [Abstract][Full Text] [Related]
6. Relative contributions of NK and CD8 T cells to IFN-gamma mediated innate immune protection against Listeria monocytogenes. Berg RE; Crossley E; Murray S; Forman J J Immunol; 2005 Aug; 175(3):1751-7. PubMed ID: 16034116 [TBL] [Abstract][Full Text] [Related]
7. Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae. Rottenberg ME; Gigliotti Rothfuchs A; Gigliotti D; Ceausu M; Une C; Levitsky V; Wigzell H J Immunol; 2000 May; 164(9):4812-8. PubMed ID: 10779789 [TBL] [Abstract][Full Text] [Related]
8. NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. Feng CG; Kaviratne M; Rothfuchs AG; Cheever A; Hieny S; Young HA; Wynn TA; Sher A J Immunol; 2006 Nov; 177(10):7086-93. PubMed ID: 17082625 [TBL] [Abstract][Full Text] [Related]
9. Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi. Sardinha LR; Elias RM; Mosca T; Bastos KR; Marinho CR; D'Império Lima MR; Alvarez JM Infect Immun; 2006 Apr; 74(4):2031-42. PubMed ID: 16552032 [TBL] [Abstract][Full Text] [Related]
10. IFN-alpha beta-dependent, IFN-gamma secretion by bone marrow-derived macrophages controls an intracellular bacterial infection. Rothfuchs AG; Gigliotti D; Palmblad K; Andersson U; Wigzell H; Rottenberg ME J Immunol; 2001 Dec; 167(11):6453-61. PubMed ID: 11714812 [TBL] [Abstract][Full Text] [Related]
11. Neither classical nor alternative macrophage activation is required for Pneumocystis clearance during immune reconstitution inflammatory syndrome. Zhang ZQ; Wang J; Hoy Z; Keegan A; Bhagwat S; Gigliotti F; Wright TW Infect Immun; 2015 Dec; 83(12):4594-603. PubMed ID: 26371121 [TBL] [Abstract][Full Text] [Related]
12. SOCS-1 protects against Chlamydia pneumoniae-induced lethal inflammation but hampers effective bacterial clearance. Yang T; Stark P; Janik K; Wigzell H; Rottenberg ME J Immunol; 2008 Mar; 180(6):4040-9. PubMed ID: 18322213 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of ethanol on IFN-gamma- and TNF-alpha-producing splenic T lymphocytes in a murine model of gram-negative pneumonia. Lanzke N; Kleinwächter R; Kerschischnik S; Sargsyan L; Groneberg DA; Kamradt T; Liesenfeld O; Krenn V; Sander M; Spies C Addict Biol; 2007 Mar; 12(1):59-68. PubMed ID: 17407498 [TBL] [Abstract][Full Text] [Related]
14. Generation of antifungal effector CD8+ T cells in the absence of CD4+ T cells during Cryptococcus neoformans infection. Lindell DM; Moore TA; McDonald RA; Toews GB; Huffnagle GB J Immunol; 2005 Jun; 174(12):7920-8. PubMed ID: 15944298 [TBL] [Abstract][Full Text] [Related]
15. Multiple Chlamydia pneumoniae antigens prime CD8+ Tc1 responses that inhibit intracellular growth of this vacuolar pathogen. Wizel B; Starcher BC; Samten B; Chroneos Z; Barnes PF; Dzuris J; Higashimoto Y; Appella E; Sette A J Immunol; 2002 Sep; 169(5):2524-35. PubMed ID: 12193722 [TBL] [Abstract][Full Text] [Related]
16. CD8+ T cell protective immunity against Chlamydia pneumoniae includes an H2-M3-restricted response that is largely CD4+ T cell-independent. Tvinnereim A; Wizel B J Immunol; 2007 Sep; 179(6):3947-57. PubMed ID: 17785832 [TBL] [Abstract][Full Text] [Related]
17. Predominant role of interferon-γ in the host protective effect of CD8(+) T cells against Neospora caninum infection. Correia A; Ferreirinha P; Botelho S; Belinha A; Leitão C; Caramalho Í; Teixeira L; González-Fernandéz Á; Appelberg R; Vilanova M Sci Rep; 2015 Oct; 5():14913. PubMed ID: 26449650 [TBL] [Abstract][Full Text] [Related]
18. Depletion of CD4+ T cells precipitates immunopathology in immunodeficient mice infected with a noncytocidal virus. Christensen JP; Bartholdy C; Wodarz D; Thomsen AR J Immunol; 2001 Mar; 166(5):3384-91. PubMed ID: 11207295 [TBL] [Abstract][Full Text] [Related]
19. Antigen-specific CD4+ T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection. Li W; Murthy AK; Guentzel MN; Seshu J; Forsthuber TG; Zhong G; Arulanandam BP J Immunol; 2008 Mar; 180(5):3375-82. PubMed ID: 18292563 [TBL] [Abstract][Full Text] [Related]
20. IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain. Villegas-Mendez A; Greig R; Shaw TN; de Souza JB; Gwyer Findlay E; Stumhofer JS; Hafalla JC; Blount DG; Hunter CA; Riley EM; Couper KN J Immunol; 2012 Jul; 189(2):968-79. PubMed ID: 22723523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]